Literature DB >> 12823782

Alemtuzumab in lymphoproliferate disorders.

Claire E Dearden1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12823782     DOI： 10.1046/j.1468-0734.2002.00308.x

Source DB:  PubMed          Journal:  Rev Clin Exp Hematol        ISSN： 1127-0020


× No keyword cloud information.
  3 in total

1.  Innovative monoclonal antibody therapies in multiple sclerosis.

Authors:  Ralf A Linker; Bernd C Kieseier
Journal:  Ther Adv Neurol Disord       Date:  2008-07       Impact factor: 6.570

2.  Suppression of neuro inflammation in experimental autoimmune encephalomyelitis by glia maturation factor antibody.

Authors:  Smita Zaheer; Yanghong Wu; Shailendra K Sahu; Asgar Zaheer
Journal:  Brain Res       Date:  2010-12-10       Impact factor: 3.252

3.  Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.

Authors:  Johanna Prinz; Aylin Karacivi; Eva R Stormanns; Mascha S Recks; Stefanie Kuerten
Journal:  PLoS One       Date:  2015-12-11       Impact factor: 3.240
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.